Literature DB >> 18345968

Chronic daily headache.

Giuseppe Nappi1, Armando Perrotta, Paolo Rossi, Giorgio Sandrini.   

Abstract

The term chronic daily headache (CDH) identifies a heterogeneous group of headaches characterized by the presence of daily or near-daily headache, including forms associated with medication overuse. This group includes chronic (transformed) migraine, chronic tension-type headache, new daily-persistent headache and hemicrania continua. According to population studies, CDH affects 4-5% of the general population worldwide, making it a significant social problem. CDH evolves from an episodic form of headache or, more rarely, is daily from onset. The classification of CDH continues to be debated, even though the recent revision of the diagnostic criteria for several primary headache forms seems to have resolved some of the nosographical difficulties. To date, no specific therapies have been approved for CDH and there have been few large-scale controlled trials of treatments in this area. This article reviews various aspects of CDH: classification issues, pathophysiological hypotheses and therapeutic (pharmacological and nonpharmacological) approaches.

Entities:  

Mesh:

Year:  2008        PMID: 18345968     DOI: 10.1586/14737175.8.3.361

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  5 in total

1.  Impact of genetic causal information on medical students' clinical encounters with an obese virtual patient: health promotion and social stigma.

Authors:  Susan Persky; Collette P Eccleston
Journal:  Ann Behav Med       Date:  2011-06

2.  Low omega-6 vs. low omega-6 plus high omega-3 dietary intervention for chronic daily headache: protocol for a randomized clinical trial.

Authors:  Christopher E Ramsden; J Douglas Mann; Keturah R Faurot; Chanee Lynch; Syed Taha Imam; Beth A MacIntosh; Joseph R Hibbeln; James Loewke; Sunyata Smith; Rebecca Coble; Chirayath Suchindran; Susan A Gaylord
Journal:  Trials       Date:  2011-04-15       Impact factor: 2.279

3.  Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study.

Authors:  Giorgio Sandrini; Armando Perrotta; Cristina Tassorelli; Paola Torelli; Filippo Brighina; Grazia Sances; Giuseppe Nappi
Journal:  J Headache Pain       Date:  2011-04-16       Impact factor: 7.277

4.  The prevalence of female sexual dysfunction among migraine patients.

Authors:  Mohammad Abdollahi; Mansoureh Toghae; Firoozeh Raisi; Elaheh Saffari
Journal:  Iran J Neurol       Date:  2015-01-05

5.  Nasal decongestant and chronic headache: a case of naphazoline overuse headache?

Authors:  Cherubino Di Lorenzo; Gianluca Coppola; Valeria La Salvia; Francesco Pierelli
Journal:  F1000Res       Date:  2013-11-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.